Last reviewed · How we verify

NCT05014763

Peri-implant Tissue Stability Following Tissue Augmentation Harvested From Deep Palate or Tuberosity

Status unknown NA Last updated 20 August 2021
What this trial tests

NA trial testing connective tissue graft in Alveolar Ridge Augmentation in 34 participants. Status unknown.

Timeline
20 September 2021
Primary endpoint
20 September 2022
20 December 2022

Quick facts

Lead sponsorTehran University of Medical Sciences
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment34
Start date20 September 2021
Primary completion20 September 2022
Estimated completion20 December 2022
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Tehran University of Medical Sciences

Who can join

18 and older, any sex, with Alveolar Ridge Augmentation or Tissue Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare peri implant tissue stability following connective tissue graft harvested fromLateral Palate or the Tuberosity Area. As far as we know, it remains controversial whether peri-implant soft tissue stability could be achieved after soft tissue augmentation with the connective tissue graft from the tuberosity or the lateral palate. Soft tissue stability evaluated by intra oral scanner will be described as primary outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of connective tissue graft

Trials testing the same drug.

Other recruiting trials for Alveolar Ridge Augmentation

Currently open trials in the same condition.

Other Tehran University of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05014763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing